Treatment of type I endoleak rests on ensuring chosen device outlives the patient


Anna Prent (London, UK) chats to Vascular News at London Aortic Symposium (11–12 October 2018, London, UK), about the need to treat type I endoleaks due to the “high risk of secondary sac perfusion and rupture”.

Patients should receive “tailor-made treatment” says Prent, who notes that there is no “one size fits all” or “perfect endovascular solution”. Centres should focus on what they specialise in but different treatment options also need to continuously be developed, she adds. “Most importantly,” Prent concludes: “we need to make sure that the device outlives the patient”.


Please enter your comment!
Please enter your name here